Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Today 12:54 EST
From CNBC.com News
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
From CNBC.com News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
From CNBC.com News
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
From CNBC.com News
5 things to know before the stock market opens Thursday
October 03, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.